Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Baxter announced an agreement to acquire two hemostat and sealant products from Mallinckrodt: RECOTHROM Thrombin topical and PREVELEAK Surgical Sealant.
read more
Baxter announced receipt of a major R&D grant from the German BMBF’s “From Material to Innovation” program to lead a consortium investigating an anticoagulation-free HD option for ESRD.
read more
Baxter International announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables pharmaceutical company.
read more
Thursday, January 22, 2015
The Pharma & Biopharma Outsourcing Association (PBOA) today announced that Nelson Patterson, Vice President, Sales and Marketing at Baxter BioPharma Solutions, has been elected to its Board of Trustees, effective immediately. Mr. Patterson was ...
read more
Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19 recombinant nanoparticle vaccine candidate.
read more
Baxter announced the FDA clearance of the Spectrum IQ Infusion System with Dose IQ Safety Software.
read more
Wednesday, March 06, 2019
Baxter announced the U.S. Food and Drug Administration (FDA) approval and launch of ready-to-use eptifibatide.
read more
Wednesday, August 01, 2018
Baxter announced the CE marking of the Evo IQ Infusion System.
read more
Wednesday, November 17, 2021
Baxter International, a global leader in sterile medication production and delivery, today announced an approximately $100 million expansion of its sterile fill/finish manufacturing facility located in Halle/Westfalen, Germany.
read more
Friday, February 08, 2019
ProvideGx, a subsidiary of Premier is collaborating with Baxter Healthcare Corporation to make additional generic drugs available for purchase through Premier’s group purchasing organization.
read more
Friday, December 04, 2020
Baxter announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, Indiana.
read more
Monday, December 18, 2017
Bausch + Lomb, has begun distributing VYZULTA 0.024% to U.S. wholesale pharmaceutical distributors.
read more
Wednesday, January 10, 2018
Battelle has been awarded a contract by the IARPA to develop threat assessment software to help prevent the creation of dangerous organisms.
read more
Wednesday, September 11, 2024
Battelle and subcontractor CMC Pharmaceuticals announced their selection by the U.S. Department of Defense (DOD) to develop an improved nerve agent countermeasure to enhance the current standard of care for the warfighter and increase survivability.
read more
Batavia Biosciences and Valneva Sweden have entered into a collaboration agreement to accelerate market-access of a low-cost IPV.
read more